MRRPhysical AI
intelligence
← Company intelligence

Robot maker · registered

PROCEPT BioRobotics

Corporate marketmedicalCurated record
procept-biorobotics.com

HYDROS Robotic System uses FirstAssist AI (Gen 2 cleared by FDA Q1 2026) for ultrasound-guided autonomous treatment planning; real-time multidimensional imaging combines transrectal ultrasound and cystoscopy; AI selects resection zone based on prostate anatomy; robotic waterjet executes ablation without heat; trained on 50,000+ procedures; de novo FDA authorization 2017 (AquaBeam), 510(k) clearance 2024-08-21 (HYDROS).

HeadquartersSan Jose, US
Founded2009
Corporate funding$537M
Team501-1000
Deployments4
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StagePublic (Nasdaq: PRCT)
FoundersNikolai Aljuri, Dr. Rodney Perkins
Regions servedNorth America, Europe, Asia-Pacific
Countries deployedUS, DE, FR, GB, JP, AU, KR, CA
Service footprintHQ Redwood City CA; US installed base 765 systems (Q1 2026); 49 HYDROS placed in Q1 2026 at ~$485K ASP; international HYDROS launch in UK March 2026; commercial presence in DE, FR, GB, JP, AU, KR, CA.
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

AquaBeam Robotic System

  • FDA de novo authorized robotic waterjet ablation system for BPH; deployed in 718+ US hospitals by end 2025

    Vendor-stated cumulative US installed base

    Claim source
Machinemedical

HYDROS Robotic System

  • AI-powered (FirstAssist AI) ultrasound-guided treatment planning

    Vendor-stated AI capability for autonomous treatment-zone selection

    Claim source
  • Single-use scope; integrated ultrasound and cystoscopy imaging

    Vendor-stated workflow and imaging configuration

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2026-04-29US hospital network (765+ AquaBeam/HYDROS systems as of Q1 2026)urology clinic networkUS765Announcement
2026-03-12UK NHS hospitals (HYDROS international launch March 2026)urology clinic networkGBNot disclosedAnnouncement
2023-08-01Japanese hospital network (first commercial procedures)hospital urology departmentJPNot disclosedAnnouncement
2017-11-01Asklepios Klinik Harburghospital urology departmentDE1Announcement
CA

Funding history

Publicly announced rounds

Investors on recordNew Enterprise Associates (NEA)Public shareholders (Nasdaq: PRCT)
TL

Company timeline

Milestones and announcements

2026-04-29Q1 2026: $83.1M revenue (+20% YoY); 765 US installed systems; 49 HYDROS placed at ~$485K ASP; FDA clearance for second-generation FirstAssist AI softwarePROCEPT BioRobotics
2026-03-12International launch of HYDROS Robotic System in UK: first international market for HYDROS; additional international markets planned 2026Yahoo Finance / PROCEPT BioRobotics
2024-08-21Received FDA 510(k) clearance for HYDROS Robotic System: next-generation AI-powered platform with FirstAssist AI treatment planningGlobeNewswire
2021-09-21IPO on Nasdaq (PRCT) raising ~$127MPROCEPT BioRobotics
2017-01-01Received FDA de novo authorization for AquaBeam Robotic System: first AI-guided robotic waterjet ablation for BPHPROCEPT BioRobotics
SC

Source ledger

20 unique public sources

01
PROCEPT BioRobotics Corporation Announces Closing of Upsized Initial Public OfferingPROCEPT BioRobotics · retrieved 2026-07-05
02
PROCEPT BioRobotics Q4 2025 Financial ResultsPROCEPT BioRobotics · retrieved 2026-07-05
03
PROCEPT BioRobotics Corporation Announces Pricing of Upsized Initial Public Offering – $25.00/share on Nasdaq PRCT; gross proceeds $188.5M including full overallotment exerciseGlobeNewswire · retrieved 2026-07-05
04
PROCEPT BioRobotics Announces $85M Financing Led by Fidelity Management & Research Company LLCPR Newswire · retrieved 2026-07-05
05
SEC Form D: $76,982,192 sold of $76,982,192 offeringSEC EDGAR · retrieved 2026-07-05
06
PROCEPT BioRobotics Announces $118 Million FinancingBioSpace · retrieved 2026-07-05
07
SEC Form D: $13,139,151 sold of $25,000,000 offeringSEC EDGAR · retrieved 2026-07-05
08
PROCEPT BioRobotics Announces Closing of $42 Million in New FundingPR Newswire · retrieved 2026-07-05
09
SEC Form D: $7,667,625 sold of $7,667,625 offeringSEC EDGAR · retrieved 2026-07-05
10
SEC Form D: $6,049,266 sold of $8,000,000 offeringSEC EDGAR · retrieved 2026-07-05
11
PROCEPT BioRobotics Q4 2025 Financial ResultsStockTitan / PROCEPT BioRobotics · retrieved 2026-07-05
12
PROCEPT BioRobotics Announces FDA Clearance of the HYDROS Robotic SystemGlobeNewswire · retrieved 2026-07-05
13
PROCEPT BioRobotics Reports First Quarter 2026 Financial ResultsStockTitan · retrieved 2026-07-05
14
PROCEPT BioRobotics Announces International Launch of the HYDROS® Robotic System in the United KingdomYahoo Finance · retrieved 2026-07-05
15
PROCEPT BioRobotics Announces First Commercial Aquablation Therapy Procedures in JapanPROCEPT BioRobotics · retrieved 2026-07-05
16
PROCEPT BioRobotics Announces Milestones in Europe: First Commercial Aquablation Cases Completed in GermanyBioSpace · retrieved 2026-07-05
17
Form 10-K for Procept Biorobotics Corp filed 02/27/2025PROCEPT BioRobotics · retrieved 2026-07-05
18
HYDROS Robotic System for BPH TreatmentPROCEPT BioRobotics · retrieved 2026-07-05
19
PROCEPT BioRobotics Reports First Quarter 2026 Financial ResultsPROCEPT BioRobotics · retrieved 2026-07-05
20
Aquablation Clinical DataPROCEPT BioRobotics · retrieved 2026-07-05